drugset / Trial / NCT03740516

Expanded Access for CC-10004

NCT03740516 ↗

Expanded access No longer available Amgen

Summary

This is an expanded access program (EAP) for eligible participants designed to provide access to CC-10004.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Apremilast Small molecule — Oral

Indications